Finance

Lists
067080:KOSDAQ
Dae Hwa Pharm Co Ltd
â‚©10,570.00
-1.21%
(-130.00) 1D
Aug 25, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 067080...
Open
â‚©10,550
High
â‚©10,590
Low
â‚©10,250
Mkt. cap
196.78B
Avg. vol.
146.62K
Volume
56.52K
Dividend
1.42%
Quarterly dividend
â‚©38
Ex-dividend date
Jun 29, 2026
P/E ratio
42.48
52-wk high
â‚©24,900
52-wk low
â‚©7,460
EPS
â‚©249
Shares outstanding
18.62M
No. of employees
365
Open
â‚©10,550
High
â‚©10,590
Low
â‚©10,250
Mkt. cap
196.78B
Avg. vol.
146.62K
Volume
56.52K
Dividend
1.42%
Quarterly dividend
â‚©38
Ex-dividend date
Jun 29, 2026
P/E ratio
42.48
52-wk high
â‚©24,900
52-wk low
â‚©7,460
EPS
â‚©249
Shares outstanding
18.62M
No. of employees
365
About Dae Hwa Pharm Co Ltd
CEOEun-Seok Kim | Byung-Tae Noh
Employees365
Founded1984
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
36.73B
33.70B
37.03B
41.29B
Cost of goods sold
24.78B
22.06B
24.61B
25.84B
Cost of revenue
24.78B
22.06B
24.61B
25.84B
Research and development expenses
1.08B
1.37B
1.22B
1.26B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.27B
9.19B
10.34B
10.32B
Operating expense
10.91B
10.94B
11.97B
12.12B
Total operating expenses
35.68B
33.00B
36.58B
37.96B
Operating income
1.05B
699.48M
453.58M
3.33B
Other non operating income
292.85M
765.41M
295.43M
334.61M
EBT including unusual items
286.29M
5.00B
-247.88M
2.72B
EBT excluding unusual items
139.10M
314.23M
-362.84M
2.54B
Income tax expense
465.08M
1.68B
17.77M
737.12M
Effective tax rate
162.45%
33.52%
-7.17%
27.10%
Other operating expenses
205.24M
89.90M
51.32M
28.29M
Net income
-428.57M
3.18B
-245.91M
1.93B
Net profit margin
-1.17%
9.43%
-0.66%
4.67%
Earnings per share
-
-
-
-
Interest and investment income
-14.79M
55.04M
55.34M
89.74M
Interest expense
-1.09B
-1.27B
-1.23B
-1.28B
Net interest expenses
-1.11B
-1.21B
-1.17B
-1.19B
Depreciation and amortization charges
85.92M
89.49M
85.76M
90.49M
EBITDA
2.62B
2.26B
2.01B
4.87B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps